Prognostic and predictive markers in breast cancer
20 Jul 2010
Prognostic and predictive markers in breast cancer
Next generation proteasome inhibitors
Treating bone disease in multiple myeloma
Views on the joint ASCO-ASH education session
Views on the joint ASCO-ASH education session
The efficacy of denosumab and zoledronic acid as treatment for prostate cancer
Circulating tumour cells in breast cancer
The influence of zoledronic acid on the treatment of endocrine-responsive early breast cancer
Frontline treatments for lymphomas
EHA 2010: Experts discuss treatment of elderly cancer patients
A new centre of excellence for lung cancer treatment
Clinical trial Design: Comparator arms